GeneDx beats Q2 estimates, raises FY guidance

12 hours ago 1

GeneDx Holdings Corp. press release (NASDAQ:WGS): Q2 GAAP EPS of $0.36 beats by $0.50.
Revenue of $102.7M (+45.7% Y/Y) beats by $17.12M.
GeneDx Full Year 2025 Guidance

GeneDx has raised certain elements of its full year 2025 guidance and expects

Recommended For You